Vol. 21 No. 1 (2023)
An Approach To:

Approach to: Adrenal mass

PDF HTML
  • Erica Bitektine
Erica Bitektine
McGill University,
molecule binding
DOI: https://doi.org/10.26443/mjm.v21i1.1050

Published 2024-01-23

Keywords

  • adrenal mass,
  • adrenal incidentaloma,
  • imaging,
  • hormones,
  • endocrinology

How to Cite

1.
Bitektine E. Approach to: Adrenal mass. McGill J Med [Internet]. 2024 Jan. 23 [cited 2025 Oct. 21];21(1). Available from: https://mjm.mcgill.ca/article/view/1050

Copyright (c) 2024 Erica Bitektine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Adrenal masses are a common incidental finding in imaging. Although most are benign, they should be thoroughly investigated to rule out malignancy and hormone hypersecretion. This article provides an approach to evaluating these adrenal masses, delving into the various differential diagnoses and special management considerations.

PDF HTML

Downloads

Download data is not yet available.

References

  1. Barzon L, Sonino N, Fallo F, Palù G, Boscaro M. Prevalence and natural history of adrenal incidentalomas. European Journal of Endocrinology. 2003;149(4):273–285
  2. Lacroix A. Clinical presentation and evaluation of adrenocortical tumors [Internet]. UpToDate. 2021 [cited 2022Dec24]. Available from: https://www.uptodate.com/contents/clinical-presentation-and-evaluation-of-adrenocortical-tumors?topicRef=153&source=see_link
  3. The Royal Australian College of general Practitioners. Incidental adrenal masses – a primary care approach [Internet]. Australian Family Physician. The Royal Australian College of general Practitioners; 2017 [cited 2022Dec24]. Available from: https://www.racgp.org.au/afp/2017/june/incidental-adrenal-masses-a-primary-care-approach
  4. Young WF, Kebebew E. Evaluation and management of the adrenal incidentaloma [Internet]. UpToDate. 2022 [cited 2022Dec24]. Available from: https://www.uptodate.com/contents/evaluation-and-management-of-the-adrenal-incidentaloma
  5. Sherlock M, Scarsbrook A, Abbas A, Fraser S, Limumpornpetch P, Dineen R, et al. Adrenal incidentaloma. Endocrine Reviews. 2020;41(6):775–820. https://doi.org/10.1210/endrev/bnaa008
  6. Angeli, A., Osella, G., Alì, A., & Terzolo, M. Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Hormone research, 1997;47(4-6), 279–283. https://doi-org.proxy3.library.mcgill.ca/10.1159/000185477
  7. Delivanis DA, Bancos I, Atwell TD, Schmit GD, Eiken PW, Natt N, et al. Diagnostic performance of unenhanced computed tomography and 18F-fluorodeoxyglucose positron emission tomography in indeterminate adrenal tumours. Clinical Endocrinology. 2017;88(1):30–6. doi:10.1111/cen.13448
  8. Kapoor A, Morris T, Rebello R. Guidelines for the management of the incidentally discovered adrenal mass. Canadian Urological Association Journal. 2011;5(4):241–7. https://doi.org/10.5489/cuaj.11135
  9. Guerin C, Pattou F, Brunaud L, Lifante J-C, Mirallié E, Haissaguerre M, et al. Performance of 18F-FDG PET/CT in the characterization of adrenal masses in noncancer patients: A prospective study. The Journal of Clinical Endocrinology & Metabolism. 2017;102(7):2465–72. doi:10.1210/jc.2017-00254
  10. Sundin A, Hindié E, Avram AM, Tabarin A, Pacak K, Taïeb D. A clinical challenge: Endocrine and imaging investigations of Adrenal Masses. Journal of Nuclear Medicine. 2021Jul;62 (Supplement 2). https://doi.org/10.2967/jnumed.120.246066
  11. Moreira SG, Pow-Sang JM. Evaluation and management of Adrenal Masses. Cancer Control. 2002;9(4):326–34. https://doi.org/10.1177/107327480200900407
  12. Fassnacht M, Arlt W, Bancos I, Dralle H, Newell-Price J, Sahdev A, et al. Management of Adrenal Incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the study of adrenal tumors. European Journal of Endocrinology. 2016;175(2). https://doi.org/10.1530/EJE-16-0467
  13. Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism. 2016;101(5):1889–916. doi:10.1210/jc.2015-4061
  14. Cobb A, Aeddula NR. Primary Hyperaldosteronism. [Internet] StatPearls 2022 [cited 2022 Dec 25]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539779/
  15. Sweeney AT, Srivoleti P, Blake MA. Management of the patient with incidental bilateral adrenal nodules. Journal of Clinical and Translational Endocrinology: Case Reports. 2021;20:100082. https://doi.org/10.1016/j.jecr.2021.100082
  16. Bourdeau I, El Ghorayeb N, Gagnon N, Lacroix A. Management of endocrine disease: Differential Diagnosis, investigation and therapy of Bilateral Adrenal Incidentalomas. European Journal of Endocrinology. 2018;179(2). https://doi.org/10.1530/EJE-18-0296
  17. Fassnacht M , Arlt W, Bancos I, et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology.2016;175(2):G1-G34.
  18. Zeiger MA, Thompson GB, Duh Q-Y, Hamrahian AH, Angelos P, Elaraj D, et al. American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons Medical Guidelines for the management of adrenal Incidentalomas: Executive summary of recommendations. Endocrine Practice. 2009;15(5):450–3. doi:10.4158/ep.15.5.450
  19. Patel D. Surgical approach to patients with pheochromocytoma. Gland Surgery. 2020;9(1):32–42. https://doi.org/10.21037/gs.2019.10.20